If you have specific questions or would like additional information regarding AzaSite® (azithromycin ophthalmic solution) 1%, please call Inspire Pharmaceuticals, Inc. at 1-888-881-4696 to speak with a healthcare professional.
Inspire Pharmaceuticals, Inc.
4222 Emperor Blvd
Suite 200
Durham, NC 27703
Please see full Prescribing Information for AzaSite®.
AzaSite® (azithromycin ophthalmic solution) 1% is indicated for the treatment of bacterial conjunctivitis caused by the following organisms: CDC coryneform group G,* Staphylococcus aureus, Streptococcus mitis group, Streptococcus pneumoniae, and Haemophilus influenzae.
The recommended dosing regimen for AzaSite® is 1 drop twice a day for 2 days, followed by 1 drop once a day for the next 5 days, for a total of 9 drops per affected eye.
Important Safety Information: AzaSite® should not be injected subconjunctivally or introduced directly into the anterior chamber of the eye or otherwise administered systemically. In clinical trials, the most common ocular adverse event was eye irritation, which occurred in 1% to 2% of patients.
*Efficacy for this organism was studied in fewer than 10 infections.
This web site is intended only for healthcare providers in the United States.
©2008 AZA-0269 May 2008 Inspire Pharmaceuticals, Inc. AzaSite and DuraSite are registered trademarks of InSite Vision, Inc. All rights reserved.